PYC Therapeutics Ltd
OTC:PYCXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
OTC:PYCXF
|
AU |
|
L
|
LKQ Corp
F:LKQ1
|
US |
|
Bilfinger SE
OTC:BFLBF
|
DE |
|
P
|
Persimmon PLC
OTC:PSMMY
|
UK |
|
P
|
Protean eGov Technologies Ltd
BSE:544021
|
IN |
|
S
|
Starpharma Holdings Ltd
OTC:SPHRF
|
AU |
|
E
|
EOG Resources Inc
XBER:EO5
|
US |
|
S
|
Schroders PLC
XBER:PYXA
|
UK |
|
Evertec Inc
NYSE:EVTC
|
PR |
|
NVR Inc
NYSE:NVR
|
US |
|
Subros Ltd
BSE:517168
|
IN |
|
Fugro NV
AEX:FUR
|
NL |
|
C
|
Consolidated Edison Inc
DUS:EDC
|
US |
|
M
|
MercadoLibre Inc
DUS:MLB1
|
UY |
|
Anoto Group AB
STO:ANOT
|
SE |
|
O
|
Omada Health Inc
NASDAQ:OMDA
|
US |
|
Z
|
Zalando SE
F:ZAL
|
DE |
|
P
|
Penumbra Inc
F:0P8
|
US |
|
L
|
Lincoln Electric Holdings Inc
F:LNE
|
US |
|
Tele2 AB
STO:TEL2 B
|
SE |
|
SIG Group AG
OTC:SCBGF
|
CH |
|
F
|
Fast Retailing Co Ltd
XMUN:FR7
|
JP |
|
IMAX China Holding Inc
OTC:IMXCF
|
CN |
Bankruptcy Probability
PYC Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PYC Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
PYC Therapeutics Ltd
ASX:PYC
|
1.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PYC Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PYC Therapeutics Ltd has total debt of 436.9k AUD. This includes both short-term (0 AUD) and long-term (436.9k AUD) debt.
You can find a full breakdown on its Balance Sheet.
